Hyundai Pharm’s paroxetine CR debuts in antidepression market

Published: 2009-03-26 06:56:00
Updated: 2009-03-26 06:56:00
Hyundai Pharm has released an oral controlled release type of antidepressant paroxetine as part of efforts to expand its product line-up.

Paroxetine CR is indicated for treatment of depression, panic disorder, social anxiety disorder, and premenstrual dysphoric disorder. Part of a class of dru...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.